Abstract
Autoimmune pancreatitis (AIP) is currently divided into two distinct histological types – type 1 and type 2 – the former now being recognized as a condition representative of IgG4-related disease (IgG4-RD). IgG4-RD is a recently recognized emerging clinicopathological entity characterized by a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells with fibrosis and usually an elevated serum IgG4 concentration [1–3]. It is now clear that various inflammatory conditions affecting multiple organs fall within the category of IgG4-RD, including sclerosing cholangitis, sialadenitis, retroperitoneal fibrosis, and periaortitis, and that these have often been described as extra-pancreatic lesions associated with type 1 AIP. In the kidney, hydronephrosis due to retroperitoneal fibrosis was first reported as a renal lesion related to type 1 AIP [4], although it was considered to be a form of secondary renal injury caused by urinary tract obstruction. Renal parenchymal lesions associated with type 1 AIP were first described in case reports of tubulointerstitial nephritis (TIN) in 2004 [5, 6]. In fact, TIN is the most dominant feature associated with IgG4-RD in the kidney and is currently referred to as IgG4-related TIN [7, 8]. However, some glomerular lesions concurrent with IgG4-related TIN have also been reported, and several radiologically identified kidney lesions including pelvic lesions have been shown to be characteristic of IgG4-RD and useful for its diagnosis, in the setting of other forms of organ involvement that have been confirmed histopathologically [9, 10]. Therefore, the term “IgG4-related kidney disease” (IgG4-RKD) has recently been proposed as a comprehensive term for the renal lesions associated with IgG4-RD, including IgG4-related TIN, glomerular lesions concurrent with IgG4-related TIN, and IgG4-related pyelitis [9, 10]. In addition, glomerular lesions without IgG4-related TIN have also recently been reported in relation to type 1 AIP. This section focuses on whole renal lesions in type 1 AIP, including IgG4-RKD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1–14.
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.
Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–4.
Takeda S, Haratake J, Kasai T, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004;19:474–6.
Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis. 2004;43:18–25.
Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016–23.
Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343–52.
Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;25:810–9.
Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.
Uchida K, Masamune A, Shimosegawa T, Okazaki K. Prevalence of IgG4-related disease in Japan based on Nationwide Survey in 2009. Int J Rheumatol. 2012;2012:358371. p. 5.
Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiollogy. 2007;242:791–801.
Fujinaga Y, Kadoya M, Kawa S, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol. 2010;76:228–38.
Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;7:3948–55.
Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32:16–21.
Inoue D, Kawano M, Yamada K, et al. Kidney and urinary tract lesions. In: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, editors. IgG4-related disease. Tokyo: Springer; 2014. p. 99–105.
Saeki T, Ito T, Onishi T, et al. IgG4-related kidney disease with retroperitoneal fibrosis in a patient with diabetes mellitus. In: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, editors. IgG4-related disease. Tokyo: Springer; 2014. p. 231–3.
Nakajima K, Inaki A, Kinuya S, et al. Scintigraphy and single-photon emission computed tomography. In: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, editors. IgG4-related disease. Tokyo: Springer; 2014. p. 123–8.
Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of gG4-related disease. Mod Pathol. 2012;25:1181–92.
Notohara K. Pancreas. In: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, editors. IgG4-related disease. Tokyo: Springer; 2014. p. 139–45.
Yoshita K, Kawano M, Mizushima I, et al. Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis. Nephrol Dial Transplant. 2012;27:2755–61.
Yamaguchi Y, Kanetsuna Y, Honda K, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2011;43:536–49.
Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2014;85:251–7.
Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455–62.
Stone JH. IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. Kidney Int. 2013;83:348–50.
Patrick H, Nachman PH, Jennette C, Falk RJ. Primary glomerular disease. In: Brenner & Rector’s the kidney. 9th ed. USA: Elsevier Inc.; 2012. p. 1100–91.
Beck Jr LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21.
Saeki T, Imai N, Ito T, et al. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol. 2009;71:173–8.
Khosroshahi A, Ayalon R, Beck Jr LH, et al. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol. 2012;2012:139409.
Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610–7.
Kuroda N, Nakamura S, Miyazaki K, et al. Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. Med Mol Morphol. 2009;42:236–8.
Zen Y, Nakanuma Y. IgG4-related sclerosing disease: renal lesions. Pathol Clin Med. 2009;27:50–6 (in Japanese).
Saeki T, Kawano M, Mizushima I, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84:826–33.
Kamisawa T, Okazaki Y, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471–7.
Acknowledgments
This work was supported in part by grants from the Health and Labour Sciences Research Grants for the Study of Intractable Disease from Ministry of Health, Labor and Welfare, Japan, and “IgG4-Related Kidney Disease” working group of the Japanese Society of Nephrology.
Disclosure
None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Saeki, T. (2015). Renal Lesions. In: Kamisawa, T., Chung, J. (eds) Autoimmune Pancreatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55086-7_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-55086-7_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-55085-0
Online ISBN: 978-3-642-55086-7
eBook Packages: MedicineMedicine (R0)